[go: up one dir, main page]

TR200101357T2 - Parkinson hastalığı, ADHD ve mikroadenomların tedavisi için ilaçlar. - Google Patents

Parkinson hastalığı, ADHD ve mikroadenomların tedavisi için ilaçlar.

Info

Publication number
TR200101357T2
TR200101357T2 TR2001/01357T TR200101357T TR200101357T2 TR 200101357 T2 TR200101357 T2 TR 200101357T2 TR 2001/01357 T TR2001/01357 T TR 2001/01357T TR 200101357 T TR200101357 T TR 200101357T TR 200101357 T2 TR200101357 T2 TR 200101357T2
Authority
TR
Turkey
Prior art keywords
microadenomas
parkinson
disease
treatment
adhd
Prior art date
Application number
TR2001/01357T
Other languages
English (en)
Inventor
Rose Jackson Elise
Mclean Stafford
Howard Zorn Stevin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200101357T2 publication Critical patent/TR200101357T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu bulus, bis-azabisiklik bilesikler olarak da bilinen ve formül (I) ile tanimli kimi pirido [1,2-a]- pirazin türevlerinin, memelilerde Parkinson hastaliginin, dikkat eksikligine bagli hiperaktivite bozuklugunun ve mikroadenomlarinin tedavisinde kullanimina ve ilgili bilesimlere iliskindir.
TR2001/01357T 1998-09-21 1999-09-03 Parkinson hastalığı, ADHD ve mikroadenomların tedavisi için ilaçlar. TR200101357T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10119198P 1998-09-21 1998-09-21
US10386898P 1998-10-12 1998-10-12

Publications (1)

Publication Number Publication Date
TR200101357T2 true TR200101357T2 (tr) 2001-08-21

Family

ID=26798000

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2004/02083T TR200402083T2 (tr) 1998-09-21 1999-09-03 Parkinson hastalığı, adhd ve mikroadenomların tedavisi için ilaçlar
TR2001/01357T TR200101357T2 (tr) 1998-09-21 1999-09-03 Parkinson hastalığı, ADHD ve mikroadenomların tedavisi için ilaçlar.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2004/02083T TR200402083T2 (tr) 1998-09-21 1999-09-03 Parkinson hastalığı, adhd ve mikroadenomların tedavisi için ilaçlar

Country Status (38)

Country Link
US (2) US6300329B1 (tr)
EP (1) EP1115402A1 (tr)
JP (1) JP2002526448A (tr)
KR (3) KR20040054752A (tr)
CN (1) CN1319013A (tr)
AP (1) AP1456A (tr)
AR (1) AR029739A1 (tr)
AU (1) AU760230B2 (tr)
BG (1) BG105445A (tr)
BR (1) BR9913975A (tr)
CA (1) CA2344670A1 (tr)
CO (1) CO5140075A1 (tr)
CZ (1) CZ20011006A3 (tr)
DZ (1) DZ2894A1 (tr)
EA (2) EA200100204A1 (tr)
EE (1) EE200100179A (tr)
GE (1) GEP20033081B (tr)
GT (1) GT199900154A (tr)
HN (1) HN1999000146A (tr)
HR (1) HRP20010209A2 (tr)
HU (1) HUP0103691A3 (tr)
ID (1) ID28028A (tr)
IL (2) IL141507A0 (tr)
IS (1) IS5852A (tr)
MA (1) MA26690A1 (tr)
MY (1) MY127939A (tr)
NO (1) NO20011409L (tr)
NZ (1) NZ509855A (tr)
OA (1) OA11653A (tr)
PA (1) PA8482001A1 (tr)
PE (1) PE20001084A1 (tr)
PL (1) PL346904A1 (tr)
SK (1) SK3592001A3 (tr)
TN (1) TNSN99177A1 (tr)
TR (2) TR200402083T2 (tr)
TW (1) TW518225B (tr)
WO (1) WO2000016777A1 (tr)
YU (1) YU21701A (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
AU2001247474A1 (en) * 2000-03-16 2001-09-24 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
GB0027020D0 (en) 2000-11-03 2000-12-20 Univ Manchester Treatment of movement disorders
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
US7132287B2 (en) 2001-06-18 2006-11-07 Psychiatric Genomics, Inc. Method for neural stem cell differentiation using 5HT-1A agonists
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
EP1784199A4 (en) * 2004-08-11 2010-06-23 Mclean Hospital Corp COMPOUNDS FOR TREATING MARIHUANA DEPENDENCE, DEDUCTION AND CONSUMPTION
MY148644A (en) 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds
GT200600414A (es) 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
PE20070523A1 (es) 2005-09-12 2007-06-28 Wyeth Corp Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
GT200600416A (es) 2005-09-12 2007-09-20 Sales salicilato y gentisato de un compuesto de piperazina
US9066903B2 (en) * 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
WO2008083442A1 (en) * 2007-01-10 2008-07-17 Brc Operations Pty Limited Method for formulating combination medications for adhd
CN101318020B (zh) * 2007-06-06 2011-09-28 四川科瑞德制药有限公司 抗焦虑或/和抗抑郁的药物组合物及用途
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance
GB201112987D0 (en) 2011-07-28 2011-09-14 Ge Healthcare Ltd Novel compound
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA
WO2014172372A1 (en) 2013-04-15 2014-10-23 Northwestern University Treatment for dopaminergic disorders
CN104892589A (zh) 2014-03-07 2015-09-09 中国科学院上海药物研究所 一类杂环化合物、其制备方法和用途
WO2016186968A1 (en) 2015-05-15 2016-11-24 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating motor disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
WO1992000075A1 (en) * 1990-06-29 1992-01-09 Pfizer Inc. Pyridopyrazine derivatives for treating substance abuse and addiction
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
GB9408084D0 (en) * 1994-04-23 1994-06-15 Boots Co Plc Medical treatment
JP2860604B2 (ja) * 1994-06-14 1999-02-24 ファイザー インク． 中枢ドーパミン作動活性を有するベンズイミダゾロン誘導体
US5877183A (en) * 1996-06-06 1999-03-02 Ergo Research Corporation Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.

Also Published As

Publication number Publication date
TR200402083T2 (tr) 2004-10-21
AP2001002102A0 (en) 2001-03-31
AR029739A1 (es) 2003-07-16
PL346904A1 (en) 2002-03-11
BR9913975A (pt) 2001-06-19
KR20040054752A (ko) 2004-06-25
MA26690A1 (fr) 2004-12-20
CN1319013A (zh) 2001-10-24
NO20011409L (no) 2001-03-28
IS5852A (is) 2001-02-20
PE20001084A1 (es) 2000-10-18
OA11653A (en) 2004-12-08
HUP0103691A3 (en) 2003-01-28
AU5383199A (en) 2000-04-10
GT199900154A (es) 2001-03-06
EP1115402A1 (en) 2001-07-18
HRP20010209A2 (en) 2002-04-30
EA200301063A1 (ru) 2004-12-30
YU21701A (sh) 2004-07-15
TW518225B (en) 2003-01-21
AU760230B2 (en) 2003-05-08
GEP20033081B (en) 2003-10-27
MY127939A (en) 2007-01-31
DZ2894A1 (fr) 2003-12-15
NO20011409D0 (no) 2001-03-20
JP2002526448A (ja) 2002-08-20
IL164839A0 (en) 2005-12-18
HUP0103691A2 (hu) 2002-02-28
IL141507A0 (en) 2002-03-10
PA8482001A1 (es) 2000-05-24
BG105445A (en) 2001-12-29
CO5140075A1 (es) 2002-03-22
EE200100179A (et) 2002-10-15
US6300329B1 (en) 2001-10-09
KR20010075222A (ko) 2001-08-09
EA200100204A1 (ru) 2001-08-27
CA2344670A1 (en) 2000-03-30
HN1999000146A (es) 2000-11-11
KR100468340B1 (ko) 2005-01-27
TNSN99177A1 (fr) 2005-11-10
US20010034347A1 (en) 2001-10-25
ID28028A (id) 2001-05-03
CZ20011006A3 (cs) 2001-09-12
SK3592001A3 (en) 2001-12-03
AP1456A (en) 2005-09-30
WO2000016777A1 (en) 2000-03-30
KR20030088512A (ko) 2003-11-19
NZ509855A (en) 2003-04-29
US6608064B2 (en) 2003-08-19

Similar Documents

Publication Publication Date Title
TR200101357T2 (tr) Parkinson hastalığı, ADHD ve mikroadenomların tedavisi için ilaçlar.
TR200000197T2 (tr) Yeni bileşimler
TR199800012T1 (tr) Piroloprimidinler ve preparasyon için tatbikler.
TR200003011T2 (tr) Yeni dihidropirimidinler.
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
AU2795000A (en) Epothilone derivatives and their use as antitumor agents
BRPI0413022A (pt) derivados de 3-amino cromado e 2-amino tetralina
DK0741710T3 (da) Chlorpyrimidin-mellemprodukter
DE69710490D1 (de) Triazolo(4,5-d)pyrimidinyl-derivate und ihre verwendung als medikamente
TR199900856T2 (tr) Bronsla ilgili terapi maddeleri olarak benzonaftiridinler
TR200000152T2 (tr) Yeni bileşikler.
BR0116481A (pt) Compostos de heterociclilalquilindol ou azaindol como ligandos de 5-hidroxitriptamina-6
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
SE9804212D0 (sv) Compounds
BR9807883A (pt) Compostos de tetraidropirido
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
ATE209648T1 (de) 2,7,-substituierte octahydro-1h-pyrido(1,2- a)pyrazin derivate
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
DE60206599D1 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
FR2446279A1 (fr) Cis- et trans-3-aryloxy-4-hydroxypyrrolidines et leurs derives, utiles notamment en medecine veterinaire comme antidepresseurs
ATE345343T1 (de) Triazolo(4,5-d)pyrimidinderivate als antithrombotische verbindungen
BR0112092A (pt) 2-aminoalquiltieno[2,3-d]pirimidinas
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
ECSP993150A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas
SE0004098D0 (sv) Novel compounds